Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples

Journal of Proteomics

Volumn 75, Issue 1, 2011, Pages 202-210

  Végvári, Ákos ^a   Rezeli, Melinda ^a   Häkkinen, Jari ^a   Sihlbom, Carina ^b   Carlsohn, Elisabet ^b   Malm, Johan ^a   Lilja, Hans ^a,c   Laurell, Thomas ^a,d   Marko Varga, György ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Dongguk University   (South Korea)

Author keywords

ESI LTQ FT ICR; Kallikrein 2; MALDI LTQ Orbitrap XL; Prostate specific antigen isoforms; Proteios software environment

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; ISOPROTEIN; PEPTIDE FRAGMENT; TRYPSIN;

ANTIGEN DETECTION; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; SEARCH ENGINE; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; BIOLOGY; CHEMISTRY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PATHOLOGY; PROSTATE TUMOR;

AMINO ACID SEQUENCE; COMPUTATIONAL BIOLOGY; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; SOFTWARE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRYPSIN;

EID: 84858734563     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.06.008     Document Type: Article

References (20)

1. Végvári Á., Rezeli M., Welinder C., Malm J., Lilja H., Marko-Varga G., et al. Identification of prostate specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms. J Proteomics 2010, 73:1137-1147.
2. Armbruster D.A. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 1993, 39:181-195.
3. Bélanger A., van Halbeek H., Graves H.C.B., Grandbois K., Stamey T.A., Huang L., et al. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate 1995, 27:187-197.
4. Zhang W.-M., Leinonen J., Kalkkinen N., Dowell B., Stenman U.-H. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem 1995, 41:1567-1573.
5. Tabares G., Radcliffe C.M., Barrabes S., Ramirez M., Aleixandre R.N., Hoesel W., et al. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 2006, 16:132-145.
6. Hilz H., Noldus J., Hammerer P., Buck F., Lück M., Huland H. Molecular heterogeneity of free PSA in sera of patients with benign and malignant prostate tumors. Eur Urol 1999, 36:286-292.
7. Isono T., Tanaka T., Kageyama S., Yoshiki T. Structural diversity of cancer-related and non-cancer-related prostate-specific antigen. Clin Chem 2002, 48:2187-2194.
8. Okada T., Sato Y., Kobayashi N., Sumida K., Satomura S., Matsuura S., et al. Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid. Biochim Biophys Acta 2001, 1525:149-160.
9. Prakash S., Robbins P.W. Glycotyping of prostate specific antigen. Glycobiology 2000, 10:173-176.
10. Mikolajczyk S.D., Grauer L.S., Millar L.S., Hill T.M., Kumar A., Rittenhouse H.G., et al. A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum. Urology 1997, 50:710-714.
11. Mikolajczyk S.D., Millar L.S., Wang T.J., Rittenhouse H.G., Wolfert R.L., Marks L.S., et al. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia. Urology 2000, 55:41-45.
12. Noldus J., Chen Z., Stamey T.A. Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer. J Urol 1997, 158:1606-1609.
13. Fung K.Y.C., Glode L.M., Green S., Duncan M.W. A comprehensive characterization of the peptide and protein constituents of human seminal fluid. Prostate 2004, 61:171-181.
14. Peter J., Unverzagt C., Krogh T.N., Vorm O., Hoesel W. Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry. Cancer Res 2001, 61:957-962.
15. Barnidge D.R., Goodmanson M.K., Klee G.G., Muddiman D.C. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry. J Proteome Res 2004, 3:644-652.
16. Jung K., Reiche J., Boehme A., Stephan C., Loening S.A., Schnorr D., et al. Analysis of subforms of free prostate-specific antigen in serum by two-dimensional gel electrophoresis: potential to improve diagnosis of prostate cancer. Clin Chem 2004, 50:2292-2301.
17. Dickson E.F., Pollak A., Diamandis E.P. Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol Ther 1995, 66:207-235.
18. Häkkinen J., Vincic G., Månsson O., Wårell K., Levander F. The Proteios software environment: an extensible multiuser platform for management and analysis of proteomics data. J Proteome Res 2009, 8:3037-3043.
19. Levander F., Krogh M., Wårell K., Gärdén P., James P., Häkkinen J. Automated reporting from gel-based proteomics experiments using the open source Proteios database application. Proteomics 2007, 7:668-674.
20. Kersey P.J., Duarte J., Williams A., Karavidopoulou Y., Birney E., Apweiler R. The International Protein Index: an integrated database for proteomics experiments. Proteomics 2004, 4:1985-1988.